Early versus Later Anticoagulation for Stroke with Atrial FibrillationUrs Fischer, Martina Göldlin, Masatoshi Koga et al.|New England Journal of Medicine|2023Cited by 217
Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non–Vitamin K Antagonist Oral Anticoagulants for Stroke PreventionMaurizio Paciaroni, Simona Marcheselli, Alexandros A. Polymeris et al.|Stroke|2019Cited by 95
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND StudyMaurizio Paciaroni, Lucia Pavolucci, Valeria Caso et al.|Stroke|2022Cited by 73
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trialUrs Fischer, Sven Trelle, Mattia Branca et al.|European Stroke Journal|2022Cited by 37